Amedisys/ US0234361089 /
04/09/2024 21:59:56 | Chg. +0.17 | Volume | Bid- | Ask- | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
97.65USD | +0.17% | 19,801 Turnover: 1.93 mill. |
-Bid Size: - | -Ask Size: - | 3.2 bill.USD | - | - |
Assets
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Property and Equipment | 42.6950 | 36.9990 | 31.1000 | 29.4490 | 28.1000 | ||||||
Intangible Assets | 44.0470 | 46.7550 | 46.0610 | 44.1320 | 64.7000 | ||||||
Long-Term Investments | - | - | - | - | - | ||||||
Fixed Assets | 509.8220 | 519.1190 | 502.3260 | 493 | 912.1910 | ||||||
Inventories | - | - | - | - | - | ||||||
Accounts Receivable | 125.0100 | 166.0560 | 201.1960 | 188.9720 | 237.5960 | ||||||
Cash and Cash Equivalents | 27.5020 | 30.1970 | 86.3630 | 20.2290 | 30.3000 | ||||||
Current Assets | 175.2630 | 214.9100 | 311.1560 | 224.1180 | 350.5540 | ||||||
Total Assets | 685.0850 | 734.0290 | 813.4820 | 717.1180 | 1,262.7450 |
Liabilities
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Accounts Payable | 25.6820 | 30.3580 | 25.3840 | 28.5310 | 31.2590 | ||||||
Long-term debt | 95 | 87.8090 | 78.2000 | 5.7750 | 232.3000 | ||||||
Liabilities to Banks | 100 | 93 | 88.8000 | 5.8000 | 232.3000 | ||||||
Provisions | - | - | - | 1.6000 | 37.7000 | ||||||
Liabilities | 274.6490 | 272.8870 | 297.0560 | 234.4850 | 621.2320 | ||||||
Share Capital | .0350 | .0350 | .0350 | .0360 | .0370 | ||||||
Total Equity | 410.4360 | 461.1420 | 516.4260 | 482.6330 | 641.5130 | ||||||
Minority Interests | .8680 | .9390 | 1.1050 | 1.0510 | 1.0630 | ||||||
Total liabilities equity | 685.0850 | 734.0290 | 813.4820 | 717.1180 | 1,262.7450 |
Income Statement
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1,280.5410 | 1,437.4540 | 1,533.7000 | 1,662.5780 | 1,955.6000 | ||||||
Depreciation (total) | 20.0360 | - | - | - | - | ||||||
Operating Result | -9.1660 | 57.3400 | 78.5240 | 155.1000 | 177.5000 | ||||||
Interest Income | -10.7120 | -5.0890 | -4.8730 | -7.0920 | -14.4370 | ||||||
Income Before Taxes | -.3080 | 61.5660 | 80.8010 | 158.9880 | 170.4100 | ||||||
Income Taxes | -2.0040 | -23.9350 | -50.1000 | -38.8590 | -42.5000 | ||||||
Minority Interests Profit | -.7090 | -.3700 | -.3820 | -.7830 | -1.0740 | ||||||
Net Income | -3.0210 | 37.2610 | 30.3000 | 119.3460 | 126.8000 |
Per Share
Cash Flow
2015 US GAAP in mill. USD |
2016 US GAAP in mill. USD |
2017 US GAAP in mill. USD |
2018 US GAAP in mill. USD |
2019 US GAAP in mill. USD |
|||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Cash Flow from Operating Activities | 107.7850 | 62.2590 | 105.7310 | 223.4830 | 202 | ||||||
Cash Flow from Investing Activities | -67.4210 | -52.0490 | -44.0270 | -22.1930 | -352.9480 | ||||||
Cash Flow from Financing | -20.8940 | -7.5150 | -5.5380 | -267.4240 | 227.2090 | ||||||
Decrease / Increase in Cash | 19.4700 | 2.6950 | 56.1660 | -66.1340 | 76.2610 | ||||||
Employees | 16,100 | 16,000 | 17,900 | 21,000 | 21,300 |